- Home
- GOSS vs ACNB Comparison
GOSS vs ACNB Comparison
Compare GOSS & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- ACNB
- Stock Information
- Founded
- GOSS 2015
- ACNB 1857
- Country
- GOSS United States
- ACNB United States
- Employees
- GOSS N/A
- ACNB N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- GOSS Health Care
- ACNB Finance
- Exchange
- GOSS Nasdaq
- ACNB Nasdaq
- Market Cap
- GOSS 501.2M
- ACNB 468.6M
- IPO Year
- GOSS 2019
- ACNB N/A
- Fundamental
- Price
- GOSS $3.17
- ACNB $46.48
- Analyst Decision
- GOSS Strong Buy
- ACNB Strong Buy
- Analyst Count
- GOSS 6
- ACNB 3
- Target Price
- GOSS $8.60
- ACNB $50.67
- AVG Volume (30 Days)
- GOSS 3.1M
- ACNB 18.8K
- Earning Date
- GOSS 11-05-2025
- ACNB 10-23-2025
- Dividend Yield
- GOSS N/A
- ACNB 3.25%
- EPS Growth
- GOSS N/A
- ACNB N/A
- EPS
- GOSS N/A
- ACNB 3.34
- Revenue
- GOSS $44,051,000.00
- ACNB $136,676,000.00
- Revenue This Year
- GOSS N/A
- ACNB $41.47
- Revenue Next Year
- GOSS $16.11
- ACNB $3.31
- P/E Ratio
- GOSS N/A
- ACNB $13.98
- Revenue Growth
- GOSS N/A
- ACNB 28.45
- 52 Week Low
- GOSS $0.66
- ACNB $35.70
- 52 Week High
- GOSS $3.60
- ACNB $49.25
- Technical
- Relative Strength Index (RSI)
- GOSS 68.68
- ACNB 50.87
- Support Level
- GOSS $2.42
- ACNB $45.64
- Resistance Level
- GOSS $2.71
- ACNB $48.54
- Average True Range (ATR)
- GOSS 0.19
- ACNB 1.38
- MACD
- GOSS 0.09
- ACNB -0.09
- Stochastic Oscillator
- GOSS 96.48
- ACNB 58.59
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.